Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2014
03/19/2014EP2707026A1 Production of dense bodies (db) from hcmv-infected cells
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649074A Substituted azaheterocycles for the treatment of cancer
03/19/2014CN103649073A 17alpha-hydroxylase/c17,20-lyase inhibitors
03/19/2014CN103649056A Fused heterocyclic compounds as sodium channel modulators
03/19/2014CN103649053A Aminomethyl quinolone compounds
03/19/2014CN103648500A Methods and use of bifunctional enzyme-building clamp-shaped molecules
03/19/2014CN103641833A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641815A Production improvement process of imidacloprid
03/19/2014CN103641814A 4'-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/19/2014CN103641776A Manufacturing method of N-methylene substituted methylamine polymer and triazine derivative
03/19/2014CN103641765A Modulators of ATP-binding cassette transporters
03/19/2014CN103159737B Esomeprazole sodium compound and medicine composition
03/19/2014CN103052632B Dihydropyrazole Compounds
03/19/2014CN102924436B Refining method of fasudil hydrochloride
03/19/2014CN102838588B Oral thrombin inhibitors, preparation methods and medical uses thereof
03/19/2014CN102203068B Cyclohexane derivative and pharmaceutical use thereof
03/19/2014CN101903371B Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
03/19/2014CN101454309B Synthesis and uses of pyroglutamic acid derivatives
03/18/2014US8674138 Binaphthalene derivatives, preparation method thereof and organic electronic device using the same
03/18/2014US8674135 Functionalized ionic liquids, and methods of use thereof
03/18/2014US8674113 Compounds
03/18/2014US8674109 Pesticidal compositions
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8674099 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
03/18/2014US8674093 Process for the preparation of an orexin receptor antagonist
03/18/2014US8674091 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent
03/18/2014US8673961 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
03/18/2014US8673938 Chemical compounds
03/18/2014US8673930 Pyrimidylaminobenzamide derivatives for systemic mastocytosis
03/18/2014US8673929 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
03/18/2014US8673922 Azaindazole compounds
03/18/2014US8673920 Inhibitors of the renal outer medullary potassium channel
03/18/2014US8673919 Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors
03/18/2014US8673917 2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors
03/18/2014US8673911 Inhibitors of histone deacetylase
03/18/2014US8673909 Indole compounds and methods for treating visceral pain
03/18/2014US8673904 Epoxide inhibitors of cysteine proteases
03/18/2014US8673891 Aminopyrazine derivative and medicine
03/18/2014CA2749174C Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
03/18/2014CA2743562C Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
03/18/2014CA2629915C Isoquinoline derivatives
03/18/2014CA2621182C 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
03/18/2014CA2619898C Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/18/2014CA2579665C Method and apparatus for producing oxidized compound
03/18/2014CA1341637C Chemiluminescent acridinium salts
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039714A2 Compounds and methods for kinase modulation, and indications therefor
03/13/2014WO2014039434A1 Alkoxy pyrazoles as soluble guanylate cyclase activators
03/13/2014WO2014039421A1 Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof
03/13/2014WO2014039412A1 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
03/13/2014WO2014039411A1 Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
03/13/2014WO2014038623A1 3-(4-piperidyl)-indazole derivative
03/13/2014WO2014038220A1 Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound
03/13/2014WO2014037751A1 Pharmacologically active compounds
03/13/2014WO2014037750A1 Inhibitor compounds
03/13/2014WO2014037480A1 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
03/13/2014WO2014037342A1 Herbicidally active bicycloaryl carboxylic acid amides
03/13/2014WO2014037327A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof
03/13/2014WO2014005122A3 Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
03/13/2014WO2013190508A3 1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives
03/13/2014WO2013181251A9 Crizotinib hydrochloride salt in crystalline
03/13/2014US20140073796 Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
03/13/2014US20140073783 Neprilysin inhibitors
03/13/2014US20140073782 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
03/13/2014US20140073672 Novel pyrazolone-derivatives and their use as pde-4 inhibitors
03/13/2014US20140073669 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/13/2014US20140073661 Heterocyclic compounds and uses thereof
03/13/2014US20140073660 Pyrimidylaminobenzamide Derivatives for Treatment of Neurofibromatosis
03/13/2014US20140073658 Dipyridylamine Derivative
03/13/2014US20140073642 Quinazoline derivatives for the treatment of viral infections and further diseases
03/13/2014US20140073636 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
03/13/2014US20140073634 Heterocyclic modulators of hif activity for treatment of disease
03/13/2014US20140073631 Antiviral and antimicrobial compounds
03/13/2014US20140073629 Alkoxy pyrazoles as soluble guanylate cyclase activators
03/13/2014US20140073625 Novel n-(4-(azetidine-1-carbonyl) phenyl) - (hetero-) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
03/13/2014US20140073622 Imidazole carbonyl compound
03/13/2014US20140073621 5-alkynyl-pyrimidines
03/13/2014US20140073620 Vegfr3 inhibitors
03/13/2014US20140073609 Compositions and Methods Including Cell Death Inducers and Procaspase Activation
03/13/2014US20140072555 Inhibitor Compounds and Cancer Treatment Methods
03/13/2014US20140072532 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/13/2014DE102012018115A1 New aryl-N-(arylalkyl) carbamate compounds, used to prepare pharmaceutical composition for prophylactic and/or therapeutic treatment of diseases including e.g. acute and chronic neurogenic pain, and neurological and psychiatric diseases
03/12/2014EP2705039A2 Bromodomain inhibitors and uses thereof
03/12/2014EP2705032A1 Dihydroquinoline derivatives as bromodomain inhibitors
03/12/2014EP2704572A1 Compounds for inhibiting cell proliferation in egfr-driven cancers
03/12/2014EP2704571A1 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
03/12/2014CN103626783A Dicyclic fused heterocyclic compounds, and applications and pharmaceutical compositions thereof
03/12/2014CN103626742A Bi-aryl meta-pyrimidine inhibitors of kinases
03/12/2014CN103626741A Heterocyclic aminopyrimidine compound with adenosine receptor antagonist activity
03/12/2014CN103626740A Synthetic method of compound
03/12/2014CN103626739A Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
03/12/2014CN103626738A Pomalidomide crystal and preparation method thereof
03/12/2014CN103626737A Application of triazole compound containing pyridine as bactericide
03/12/2014CN103626736A Preparation method of imatinib mesylate alpha-crystal form
03/12/2014CN102898418B Preparation method of esomeprazole magnesium
03/12/2014CN102796075B Benzocycloheptenes derivative as well as preparation method and medical application thereof
03/12/2014CN102558150B Synthesis process for sulfoxide substituted compound
03/12/2014CN102516153B 5-fluoroindole-2-one-3-carbamide compounds, preparation method thereof and application thereof
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 1080